Quirante, Joseph F.

HRN: 06-93-59  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
CEFTRIAXONE 1G (VIAL)
07/28/2026
08/04/2026
IVTT
1G
Q12HRS ANST
LAMINECTOMY, DISCECTOMY
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: